Sander Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,350
Closed -$201K 16
2020
Q3
$201K Hold
1,350
0.11% 11
2020
Q2
$190K Buy
+1,350
New +$197K 0.11% 11
2020
Q1
Sell
-2,250
Closed -$328K 8
2019
Q4
$328K Hold
2,250
0.2% 7
2019
Q3
$291K Hold
2,250
0.19% 9
2019
Q2
$313K Sell
2,250
-1,200
-35% -$166K 0.2% 10
2019
Q1
$482K Hold
3,450
0.34% 11
2018
Q4
$445K Hold
3,450
0.41% 8
2018
Q3
$477K Hold
3,450
0.33% 12
2018
Q2
$419K Sell
3,450
-650
-16% -$81.1K 0.34% 12
2018
Q1
$528K Sell
4,100
-900
-18% -$122K 0.44% 13
2017
Q4
$700K Buy
+5,000
New +$696K 0.62% 13

Other funds holding JNJ

Sander Capital Advisors's JNJ Position: Q4 2020 in Review

Sander Capital Advisors sold out of Johnson & Johnson (JNJ) in Q4 2020, closing a stake of 1,350 shares — an estimated $201K sold.

Sander Capital Advisors first reported a position in JNJ in Q4 2017 and held it in 11 quarters. The position peaked at $700K in Q4 2017. 3,266 funds tracked by Wall St. Rank hold JNJ as of Q4 2020.

  • Sander Capital Advisors reported no remaining Johnson & Johnson position as of Q4 2020 after selling out during the quarter.
  • Sander Capital Advisors sold 1,350 Johnson & Johnson shares in Q4 2020, an estimated $201K.
  • Sander Capital Advisors first reported a position in Johnson & Johnson in Q4 2017 and held it in 11 quarters.
  • Sander Capital Advisors's Johnson & Johnson position peaked at $700K in Q4 2017.
  • 3,266 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2020.

Based on Sander Capital Advisors's 13F filing for Q4 2020, filed 28 Jan 2021.